Therapeutics Company Announces Achievement In Abdominal Aortic Aneurysm Treatment
Altamira Therapeutics Announces Success in the Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles.
Disclaimer: The following article discusses preclinical research findings related to a potential treatment for abdominal aortic aneurysm (AAA) using SOD2 mRNA delivered by SemaPhore nanoparticles developed by Altamira Therapeutics. This article does not offer medical advice and should be considered informational rather than presc…